RE:RE:RE:RE:RE:Featured profile in BiotecanadaSo Proph, so far I've always appreciated your analyses and have always been glad for your information.
But what you are writing now is really - to put it positively - more than superficial.
The shareholders just want to be on the same level of information as was discussed long and wide at the publication under discussion.
And there is really no need to spend money on this.
It is clear to me that you are positive for Ceapro in every respect. But if you refuse any critical questioning, then your opinion is unfortunately little relevant for Ceapro interested people who need an objective information.